Capitalization 2.62B 2.86B 2.46B P/E ratio 2024 *
36.9x
P/E ratio 2025 * 30.9x
Enterprise value 2.75B 3.01B 2.59B EV / Sales 2024 *
4.75x
EV / Sales 2025 * 4.15x
Free-Float
30.01%
Yield 2024 *
0.57%
Yield 2025 * 0.68%
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: Medacta Group SA

1 week+0.82%
Current month-1.28%
3 months+1.82%
6 months+5.29%
Current year-1.75%
More quotes
1 week
121.00
Extreme 121
128.00
1 month
116.00
Extreme 116
128.20
Current year
107.80
Extreme 107.8
135.00
1 year
98.10
Extreme 98.1
135.00
3 years
76.70
Extreme 76.7
173.00
5 years
39.80
Extreme 39.8
173.00
10 years
39.80
Extreme 39.8
173.00
More quotes
Director TitleAgeSince
Chief Executive Officer 47 18-10-31
Director of Finance/CFO 56 07-12-31
Sales & Marketing - -
Manager TitleAgeSince
Founder 80 98-12-31
Director/Board Member 49 17-12-31
Director/Board Member 67 18-12-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
0.00%+0.82%+7.87%-11.73%2.87B
+1.15%+2.10%+19.68%-2.06%199B
+0.24%-1.83%+16.07%-29.47%113B
+0.44%-1.43%-9.23%-0.16%68.55B
+2.52%+6.68%+43.21%+29.67%48.6B
+0.16%-1.37%+20.29%+85.27%43.28B
-0.06%-1.83%+34.10%+4.71%30.8B
+1.07%+7.50%+51.81%+17.12%29.03B
+0.27%+5.48%-16.34%-47.37%27.82B
-0.03%-3.66%+1.30%+3.49%22.41B
Average +0.58%+0.28%+16.88%+4.95% 58.58B
Weighted average by Cap. +0.77%-0.56%+17.48%+1.28%
See all sector performances

Financials

2024 *2025 *
Net sales 580M 634M 546M 664M 727M 625M
Net income 70.88M 77.53M 66.73M 84.58M 92.52M 79.63M
Net Debt 138M 151M 130M 137M 150M 129M
More financial data * Estimated data
Logo Medacta Group SA
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
Employees
1,826
Calendar
More about the company
Date Price Change Volume
24-10-09 123.40 CHF 0.00% 6,248
24-10-08 123.40 CHF -3.29% 7,283
24-10-07 127.60 CHF +2.41% 8,172
24-10-04 124.60 CHF +2.13% 8,304
24-10-03 122.00 CHF -1.13% 7,592

Delayed Quote Swiss Exchange, October 09, 2024 at 11:30 am EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B
surperformance-ratings-light-chart MEDACTA-GROUP-SAMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
131.17EUR
Average target price
147.00EUR
Spread / Average Target
+12.07%
Consensus

Annual profits - Rate of surprise